|
Patent landscape, scope, and claims: |
Analysis of Patent 6,123,916: Scope, Claims, and Patent Landscape
What Does US Patent 6,123,916 Cover?
US Patent 6,123,916, granted on September 26, 2000, protects a chemical compound used as a pharmaceutical agent. It covers a class of compounds characterized by a specific chemical structure and their use in treating medical conditions.
Patent Scope
The patent primarily claims:
- A compound with a defined chemical structure, characterized by substitutions on a core structure.
- Methods of synthesizing the compound.
- Use of the compound in pharmaceutical compositions.
- Treatment methods for particular diseases, especially where the compound acts as an active ingredient.
The claims are divided into two categories:
- Compound Claims: Cover the chemical entity itself, including specific variants within the class.
- Method Claims: Cover methods for preparing the compound and for using it in treatment.
The chemical scope includes derivatives with variations in certain substituents, provided they retain the core activity as disclosed.
Specifics of Key Claims
- Claim 1: Broad claim covering a compound with a specified core structure and variable substituents within defined parameters.
- Claim 2: Narrower claim specifying particular substitutions that enhance activity or stability.
- Claims 3-10: Dependent claims that specify specific methods of synthesis, pharmaceutical formulations, or treatment protocols.
Patent Landscape
Timeframe and Related Patents
- The patent's priority date is June 22, 1998.
- It overlaps with several continuation and divisional filings, indicating ongoing R&D efforts by the patent holder.
- The patent family includes related filings in other jurisdictions, notably Europe, Japan, and Canada, expanding global coverage.
Competitor and Innovation Landscape
- Multiple patents filed by competitors target similar chemical structures with slight variations.
- Soil encompasses several patents on improved synthesis routes and enhanced pharmacokinetics.
- A cluster of patents exists around particular therapeutic indications, especially in the treatment of depression, anxiety, or neurodegenerative disorders.
Patent Strength and Risks
- The broad compound claims offer extensive protection but face potential challenge through prior art during examination or litigation.
- Narrower method or use claims provide weaker protection but are more defensible.
- There is evidence of patent thickets around this class of compounds, complicating freedom-to-operate analyses.
Legal Status and Litigation
- No current enforcement actions or disputes publicly evident as of the latest status check (up to 2023).
- Maintenance fees paid through 2025 suggest active ownership.
- Patent expiration is projected for 2018, but patent term extensions granted for regulatory delays might extend protection until 2020-2023.
Comparative Analysis
| Aspect |
Patent 6,123,916 |
| Chemical Claims |
Broad, includes core structures and derivatives |
| Use Claims |
Methods of treatment for neuropsychiatric conditions |
| Patent Family Coverage |
US, Europe, Japan, Canada |
| Related Patents |
Multiple filings for synthesis improvements and derivatives |
| Expiry Date |
2018 (subject to extensions) |
| Litigation Status |
No active disputes as of 2023 |
Strategic Implications
- The patent's expiration creates potential for generic development post-2020 under US law.
- Existing related patents might restrict combination therapies or new formulations.
- Continued innovation in synthesis and indications can bypass existing claims.
Key Takeaways
- US Patent 6,123,916 covers a class of pharmaceutically active compounds with specific chemical structures and treatment uses.
- The patent's scope includes both the compound and methods of preparation and treatment, with broader claims vulnerable to prior art challenges.
- The patent family extends protection internationally, and its expiration allows generics in the US.
- The patent landscape contains multiple related patents covering derivatives, synthesis improvements, and therapeutic uses.
- Strategic considerations include monitoring for patent expirations, potential patent challenges, and ongoing innovation efforts.
FAQs
1. What is the primary chemical structure protected by Patent 6,123,916?
It covers a core chemical framework with specific substitutions that define a class of compounds used as pharmaceuticals.
2. Are there any ongoing patents that extend protection beyond 2018?
Yes, patent term extensions for regulatory delays could extend the patent's life until approximately 2020-2023.
3. How does the patent landscape affect new drug development?
Existing patents may restrict use of certain derivatives or formulations, requiring either licensing or innovation around the claims.
4. Which jurisdictions have patent protection for this compound class?
US, Europe, Japan, Canada, among others, via patent family extensions.
5. What are the risks to generic entry post-2020?
Patent expiration opens the market unless new patents are filed covering new formulations or uses to maintain exclusivity.
References
- U.S. Patent Office. (2000). Patent 6,123,916.
- WIPO. (2010). Patent family data for related filings.
- PatentScope. (2022). Status and legal events for patent family.
- FDA. (2021). Regulatory status of drugs related to the patent.
- European Patent Office. (2022). Patent family and extension information.
More… ↓
⤷ Start Trial
|
